Literature DB >> 15702250

Identification and characterization of rat Ror1 and Ror2 genes in silico.

Masuko Katoh1, Masaru Katoh.   

Abstract

Frizzled-1 (FZD1), FZD2, FZD3, FZD4, FZD5, FZD6, FZD7, FZD8, FZD9 and FZD10 are seven-transmembrane-type WNT receptors with extracellular Frizzled (Fz) domain. ROR1, ROR2 and MUSK are receptor-type tyrosine kinases with extracellular Fz domain, while MFRP is type II transmembrane protein with extracellular Fz domain. ROR1, ROR2, MUSK and MFRP are predicted to transduce or regulate WNT signaling. Here, we identified and characterized rat Ror1 and Ror2 genes by using bioinformatics. Rat Ror1 gene was located within AC108320.4, AC098031.5 and AC129856.4 genome sequences, while rat Ror2 gene was located within AC139870.3 and AC123431.4 genome sequences. Exon-intron structure was conserved between rat Ror1 and Ror2 genes, consisting of nine exons. Rat Ror1 mRNA was expressed in fetal ventricle, while rat Ror2 mRNA was expressed in cerebral cortex, hypothalamus, dorsolateral prostate, and chondrosarcoma. Rat Ror1 (937 aa) and Ror2 (943 aa) showed 56.5% total-amino-acid identity. Rat Ror1 and Ror2 were type I transmembrane proteins with extracellular Immunoglobulin-like (Ig), Fz, Kringle (KR) domains, and cytoplasmic Juxta-membrane (JM), Tyrosine kinase (TK), and Ror homology C-terminal (RORHC) domains. Casein kinase Iepsilon-binding RORHC domain was conserved among vertebrate Ror1 and Ror2 homologs, but not in Drosophila Ror. Thr 582 within TK domain was conserved among mammalian Ror family members, and was predicted as Casein kinase I phosphorylation site. This is the first report on rat Ror1 and Ror2 genes as well as on molecular evolution of Ror1 and Ror2 homologs.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15702250

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  4 in total

1.  ROR1 is expressed in human breast cancer and associated with enhanced tumor-cell growth.

Authors:  Suping Zhang; Liguang Chen; Bing Cui; Han-Yu Chuang; Jianqiang Yu; Jessica Wang-Rodriguez; Li Tang; George Chen; Grzegorz W Basak; Thomas J Kipps
Journal:  PLoS One       Date:  2012-03-05       Impact factor: 3.240

2.  ROR1 expression correlated with poor clinical outcome in human ovarian cancer.

Authors:  Huilin Zhang; Jinrong Qiu; Chunping Ye; Dazhen Yang; Lingjuan Gao; Yiping Su; Xiaojun Tang; Ning Xu; Dawei Zhang; Lin Xiong; Yuan Mao; Fengshan Li; Jin Zhu
Journal:  Sci Rep       Date:  2014-07-24       Impact factor: 4.379

3.  miR-27b-3p suppresses cell proliferation through targeting receptor tyrosine kinase like orphan receptor 1 in gastric cancer.

Authors:  Jinqiu Tao; Xiaofei Zhi; Xiaoyu Zhang; Min Fu; Hao Huang; Yu Fan; Wenxian Guan; Chen Zou
Journal:  J Exp Clin Cancer Res       Date:  2015-11-14

4.  In-Silico Drug discovery approach targeting receptor tyrosine kinase-like orphan receptor 1 for cancer treatment.

Authors:  Onkar Nath; Archana Singh; Indrakant K Singh
Journal:  Sci Rep       Date:  2017-04-21       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.